Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  ResMed, Inc.    RMD

RESMED, INC.

(RMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/21/2020 05/22/2020 05/26/2020 05/27/2020 05/28/2020 Date
160.68(c) 161.35(c) 160.48(c) 153.71(c) 158.82(c) Last
471 997 426 248 761 696 1 016 072 541 069 Volume
-0.67% +0.42% -0.54% -4.22% +3.32% Change
More quotes
Financials (USD)
Sales 2020 2 921 M - -
Net income 2020 582 M - -
Net Debt 2020 863 M - -
P/E ratio 2020 38,9x
Yield 2020 1,00%
Sales 2021 3 093 M - -
Net income 2021 607 M - -
Net Debt 2021 449 M - -
P/E ratio 2021 37,3x
Yield 2021 1,06%
Capitalization 22 976 M 22 976 M -
EV / Sales 2020 8,16x
EV / Sales 2021 7,57x
Nbr of Employees 7 240
Free-Float 77,0%
More Financials
Company
ResMed specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (52.2%); - masks (37.2%); - software as a service (10.6%). At the end of June 2019, the group had 6 production sites located in the United States, Australia, France, China,... 
More about the company
Surperformance© ratings of ResMed, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on RESMED, INC.
05/27RESMED : Rugby League Legend Brad Fittler Teams Up with ResMed to Help Australia..
BU
05/26PROPELLER HEALTH : Receives FDA Clearance to Connect Patients Using the Symbicor..
BU
05/20MATRIXCARE : Celebrates Post-acute Healthcare Workers with National Heroes Progr..
BU
05/13RESMED, INC. : Ex-dividend day for
FA
05/06RESMED : Announces Participation in the Bank of America Merrill Lynch Global Hea..
BU
05/05RESMED : Accelerates Release of Ventilator Telemonitoring Platform to Enable Saf..
BU
05/04RESMED : Morgans rates RMD as Add
AQ
05/03RESMED : Is There A Slowdown Ahead For ResMed?
AQ
05/01RESMED : Company Profile for ResMed
BU
05/01RESMED : Management's Discussion and Analysis of Financial Condition and Results..
AQ
04/30RESMED INC : Results of Operations and Financial Condition, Other Events, Financ..
AQ
04/30RESMED INC. : Announces Results for the Third Quarter of Fiscal Year 2020
BU
04/15HHS Announces New Ventilator Contracts, Orders Now Totaling Over 130,000 Vent..
AQ
04/13RESMED : Asthma Hospitalizations Dropped after Louisville Power Plants Retired C..
BU
04/09RESMED : to Report Third Quarter Fiscal 2020 Earnings on April 30, 2020
BU
More news
News in other languages on RESMED, INC.
05/13RESMED, INC. : Ex-dividend day for
05/05RESMED : accélère le lancement de sa plateforme de télésurveillance de ventilate..
05/05RESMED : beschleunigt Einführung der Telemonitoring-Plattform für Beatmungsgerät..
03/24Le PDG de Tesla a acheté des respirateurs en Chine pour les États-Unis
03/24RESMED : Déclaration de ResMed sur le COVID-19
More news
Chart RESMED, INC.
Duration : Period :
ResMed, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESMED, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 160,13 $
Last Close Price 158,82 $
Spread / Highest target 25,9%
Spread / Average Target 0,82%
Spread / Lowest Target -15,6%
EPS Revisions
Managers
NameTitle
Michael J. Farrell Chief Executive Officer & Director
Robert Andrew Douglas President & Chief Operating Officer
Peter C. Farrell Non-Executive Chairman
Brett A. Sandercock Chief Financial Officer
Carlos M. Nunez Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
RESMED, INC.3.56%22 237
THERMO FISHER SCIENTIFIC3.84%133 237
DANAHER CORPORATION3.32%113 675
INTUITIVE SURGICAL, INC.-4.47%65 858
ILLUMINA, INC.6.83%53 482
BOSTON SCIENTIFIC CORPORATION-17.87%52 921